Literature DB >> 28242555

Imaging prevalence of nasal septal perforation in an urban population.

Menachem Gold1, Issac Boyack2, Nicholas Caputo3, Aaron Pearlman4.   

Abstract

OBJECTIVE: To determine the prevalence of nasal septal perforation (NSP) on CT imaging in an urban hospital setting.
METHODS: Facial bone CT scans from 3708 consecutive patients were reviewed for the presence of NSP. Size of the perforation was measured in two dimensions. Medical records were reviewed for possible risk factors.
RESULTS: The prevalence of NSP was 2.05%. The most common risk factor was a history of drug abuse. Cocaine was the most prevalent drug used.
CONCLUSION: The prevalence of NSP was more than double of that previously published, likely related to intranasal drug use in our urban population.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CT imaging; Nasal septal perforation

Mesh:

Substances:

Year:  2017        PMID: 28242555     DOI: 10.1016/j.clinimag.2017.02.002

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

Review 1.  Nasoseptal Perforation: from Etiology to Treatment.

Authors:  Carla Pereira; Alfonso Santamaría; Cristobal Langdon; Mauricio López-Chacón; José Hernández-Rodríguez; Isam Alobid
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-05       Impact factor: 4.806

2.  A CFD approach to understand nasoseptal perforations.

Authors:  M A Burgos; E Sanmiguel-Rojas; R Rodríguez; F Esteban-Ortega
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-24       Impact factor: 2.503

3.  Endoscopic measurement of nasal septum perforations.

Authors:  Jean-Claude Rosenthal; Eric L Wisotzky; Carsten Matuschek; Melanie Hobl; Anna Hilsmann; Peter Eisert; Florian C Uecker
Journal:  HNO       Date:  2021-10-11       Impact factor: 1.284

4.  [Endoscopic measurement of nasal septum perforations. German version].

Authors:  Jean-Claude Rosenthal; Eric L Wisotzky; Carsten Matuschek; Melanie Hobl; Anna Hilsmann; Peter Eisert; Florian C Uecker
Journal:  HNO       Date:  2021-09-03       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.